Alphatec Holdings, Inc. (ATEC) fair value analysis
Nasdaq · Updated 2026-10-19
ATEC price how computed
Valuation status
Awaiting full valuationATEC's estimate rests on a sector-average price-to-earnings multiple, not on its own validated earnings history.
TickrTrends does not publish a borrowed multiple as a verdict. A verdict publishes automatically once ATEC's own trailing P/E history validates; every covered stock is re-evaluated weekly.
- Last price
- $10.46
- Sector
- Healthcare
- 12-month range
- $6.99–$22.68
- Market cap
- $1.62B
- From 52-week high
- -53.9%
- Shares outstanding
- 154M
- Rank in Healthcare by quality score
- #49 of 301
Last price is our stored weekly price from 2026-10-16, older than the 2026-10-19 run that built this page; the chart runs through 2026-10-16.
Alphatec Holdings, Inc. is a medical technology company that designs, manufactures, and markets spinal fusion implants and related surgical instruments used in spine surgery procedures. The company operates primarily in the United States and serves hospitals, surgical centers, and healthcare providers through its sales and distribution networks.
ATEC currently ranks #49 of 301 Healthcare stocks by quality score.
Fundamentals (4 quarters) how computed
- Market cap
- $1.62B
- P/E (trailing)
- n/m
- Revenue (TTM)
- $815M
- Net margin
- -13.5%
- EPS (TTM)
- $-0.29
- Gross margin
- 72.2%
- Debt / equity
- 0.00
- Revenue growth (3-yr avg)
- 26.8%
- Shares outstanding
- 154M
Derived indicators how computed
- Quality grade
- B
- Margin trend
- Contracting
- 52-week position
- The bottom quarter of its range
Technicals how computed
- RSI (14-day)
- 50 · neutral
- 50-day average
- $9.92
- 200-day average
- $11.04
- Moving-average state
- 50-day below 200-day (death cross state); price between the averages
Earnings how computed
- Next earnings report
- 2026-10-29
- Last 8 quarters vs consensus
- 4 beat, 4 missed
- Quarter by quarter
- 2026-06 ▼ miss (-33.3%)
2026-03 ▼ miss (-6013.9%)
2025-12 ▲ beat (+60.0%)
2025-09 ▲ beat (+250.0%)
2025-06 ▲ beat (+150.0%)
2025-03 ▲ beat (+25.0%)
2024-12 ▼ miss (-70.1%)
2024-09 ▼ miss (-18.2%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 14 buy · 0 hold · 0 sell (14 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $15.8
- Target vs last price
- +51.1%
What our data shows for ATEC
- Shares are trading in the lower third of their 12-month price range of $6.99–$22.68.
- The 14-day relative strength index sits at a neutral 50.
What subscribers see
- Every published Forward Fair Value with its exact discount or premium
- The normalized P/E and quarter count behind each estimate
- Screeners and rankings across the full S&P 500 and Nasdaq universes
- ATEC's own verdict the week it qualifies, published automatically
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent ATEC news
TickrTrends' derived news-sentiment signal for ATEC is currently leaning positive, computed from recent coverage.
- Alphatec Holdings Inc (ATEC) Shares Surge 5.4% -- What GF Score of 74 Tells Investors (gurufocus.com, 2026-10-13)
- Alphatec Holdings Inc (ATEC) Stock Up 3.2% and Still Undervalued -- GF Score: 76/100 (gurufocus.com, 2026-09-29)
What people are saying
Follow the ATEC conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-05 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — ATEC's 50/200-day trend state shifted from downtrend to mixed during the week, according to TickrTrends' derived indicators. The Healthcare sector stock's current valuation verdict remains awaiting full valuation.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is ATEC stock undervalued?
ATEC's estimate rests on a sector-average price-to-earnings multiple rather than its own validated earnings history, and TickrTrends does not publish a borrowed multiple as a verdict. It is re-evaluated every week.
What is ATEC's TickrTrends verdict?
ATEC is currently marked 'Awaiting full valuation' - a verdict publishes automatically once ATEC's own trailing P/E history validates under our standards.
How does ATEC compare to other Healthcare stocks?
ATEC ranks #49 of 301 Healthcare stocks in TickrTrends' coverage by quality score. It carries no fair-value verdict yet, so it is not ranked by discount.
Is ATEC overbought or oversold?
ATEC's 14-day RSI is in neutral territory - neither overbought nor oversold.
When does ATEC report earnings next?
ATEC's next earnings report is scheduled for 2026-10-29, per the published earnings calendar.
Does ATEC usually beat earnings estimates?
Over its last 8 reported quarters ATEC beat the consensus estimate 4 times and missed 4 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about ATEC?
Of 14 analysts covering ATEC, 14 rate it a buy, 0 a hold and 0 a sell - buy-leaning, with a consensus price target of $15.8 (+51.1% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.